MITORX THERAPEUTICS

mitorx-therapeutics-logo

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

#People #Financial #Website #More

MITORX THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2016-01-01

Address:
Harwell, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.mitorxtherapeutics.com

Status:
Active

Total Funding:
0


Current Employees Featured

glyn-edwards_image

Glyn Edwards
Glyn Edwards Chairman @ MitoRx Therapeutics
Chairman
2022-02-01

Investors List

oxford-technology-management_image

Oxford Technology Management

Oxford Technology Management investment in Seed Round - MitoRx Therapeutics

longevitytech-fund_image

Longevitytech.fund

Longevitytech.fund investment in Seed Round - MitoRx Therapeutics

science-angel-syndicate_image

Science Angel Syndicate

Science Angel Syndicate investment in Seed Round - MitoRx Therapeutics

wren-capital_image

Wren Capital

Wren Capital investment in Seed Round - MitoRx Therapeutics

rainbow-seed-fund_image

UK Innovation & Science Seed Fund

UK Innovation & Science Seed Fund investment in Seed Round - MitoRx Therapeutics

the-fink-family-office_image

The Fink Family Office

The Fink Family Office investment in Seed Round - MitoRx Therapeutics

Official Site Inspections

http://www.mitorxtherapeutics.com Semrush global rank: 5.36 M Semrush visits lastest month: 1.56 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "MitoRx Therapeutics"

MitoRx Therapeutics - First-in-class mitochondrial …

Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. Mito Rx Therapeutics' first-in-class first-in-target platform …See details»

MitoWorld

MitoRx Therapeutics’ first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases, focusing internally on 3 rare indications and partnering …See details»

MitoRx Therapeutics - LinkedIn

MitoRx Therapeutics is a preclinical stage platform biotech developing a new category of innovative small molecule mitochondrial metabolic modulators for weight loss with muscle protection in ...See details»

MitoRx Therapeutics

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, …See details»

MitoRx Therapeutics - Crunchbase Company Profile & Funding

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.See details»

MitoRx Therapeutics - 2025 Company Profile - Tracxn

Apr 28, 2025 MitoRx Therapeutics - Developer of therapeutics for muscular dystrophy and neurodegenerative disorders. Raised a total funding of $5.03M over 2 rounds from 22 investors.See details»

MITORX THERAPEUTICS LIMITED overview - Find and update …

MITORX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, …See details»

MitoRx Therapeutics - VentureRadar

"MitoRx aims to become a global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction. The company is a preclinical …See details»

MitoRx Therapeutics - Craft

MitoRx Therapeutics has 5 employees across 2 locations and $4 m in total funding,. See insights on MitoRx Therapeutics including office locations, competitors, revenue, financials, executives, …See details»

About MitoRx Therapeutics - pharmiweb.jobs

Oct 8, 2024 At MitoRx our mission is to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction.See details»

Overview, News & Similar companies - ZoomInfo.com

View MitoRx Therapeutics (www.mitorxtherapeutics.com) location in Oxfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»

MitoRx Therapeutics

Dec 13, 2023 MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative …See details»

Company of the Month: MitoRx - MedCity

May 30, 2022 MitoRx Therapeutics are doing ground-breaking work to create the ideal mitochondrial medicine. After forming their company in March 2021, the co-founders Dr Jon …See details»

MitoRx Therapeutics Expands Leadership Team with Strategic

Jan 9, 2025 OXFORD, United Kingdom, Jan. 09, 2025 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial …See details»

MitoRx Therapeutics 2025 Company Profile: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for MitoRx Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Mitorx Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

For more information visit our website at www.mitorxtherapeutics.com and follow us on LinkedIn. About the University of ExeterThe University of Exeter is a Russell Group university that …See details»

MitoRx Therapeutics Company Information - Funding, Investors, …

Get information on funding, investors, industries, and more for MitoRx Therapeutics. See MitoRx Therapeutics company profile and funding data.See details»

MitoRx Therapeutics - VentureRadar

Founded at the Medical University of South Carolina, MitoChem Therapeutics was started by two scientists who saw an opportunity to focus on developing treatments to address the effects of …See details»

MitoRx Press Room

Apr 25, 2022 Check-in here for updates and press releases for MitoRx Therapeutics. Reversing mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegenerationSee details»

MitoRx Therapeutics - Halting the Progress of Degenerative …

Apr 26, 2022 MitoRx Therapeutics secures investment from Science Angel Syndicate to develop its first-in-class therapeutics that target dysfunctional sulfide-signalling in mitochondria to halt …See details»

linkstock.net © 2022. All rights reserved